KAREX BERHAD
KLSE (MYR): KAREX (5247)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.81
Today's Change
-0.005 (0.61%)
Day's Change
0.795 - 0.81
Trading Volume
470,300
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Total assets
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current assets
238
1000
110
900
600
Cash & equivalents
238
1000
110
900
600
Short term investments
238
1000
110
900
600
Total receivables, net
238
1000
110
900
600
Accounts receivable - trade, net
238
1000
110
900
600
Other receivables
238
1000
110
900
600
Total inventory
238
1000
110
900
600
Inventories - work in progress
238
1000
110
900
600
Inventories - progress payments & other
238
1000
110
900
600
Inventories - finished goods
238
1000
110
900
600
Inventories - raw materials
238
1000
110
900
600
Total non-current assets
238
1000
110
900
600
Long term investments
238
1000
110
900
600
Note receivable - long term
238
1000
110
900
600
Investments in unconsolidated subsidiaries
238
1000
110
900
600
Other investments
238
1000
110
900
600
Net property/plant/equipment
238
1000
110
900
600
Gross property/plant/equipment
238
1000
110
900
600
Accumulated depreciation, total
238
1000
110
900
600
Deferred tax assets
238
1000
110
900
600
Net intangible assets
238
1000
110
900
600
Other current assets, total
238
1000
110
900
600
Total liabilities
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current liabilities
-238
-1000
-110
-900
-600
Total non-current liabilities
-238
-1000
-110
-900
-600
Long term debt
238
1000
110
900
600
Long term debt excl. lease liabilities
238
1000
110
900
600
Capital and operating lease obligations
238
1000
110
900
600
Provision for risks & charge
-238
-1000
-110
-900
-600
Deferred tax liabilities
-238
-1000
-110
-900
-600
Other liabilities, total
-238
-1000
-110
-900
-600
Total equity
-238
-1.64%
-1000
+11.55%
-110
+81.66%
-900
-13.16%
-600
+235.36%
Total liabilities & shareholders' equities
238B
1000B
110B
900B
600B
Total debt
238
1000
110
900
600
Book value per share
-238
-1000
-110
-900
-600
Discussions
32 people like this. Showing 50 of 11,887 comments
KAREX (KAREX, 5247, main board consumer stock) closed at 67 sen on 16 November 2023
The daily chart trend of Karex may show a rebound trend, and it may moves upward towards the target price of 72 sen.
We are now waiting for its 1st results, on the day where its AGM is held, on 27 November 2023.
2023-11-17 10:34
Today 20 Nov 2023, one whole day of red (-0.01) at RM0.695 due to overbought position.
2023-11-20 18:02
Why Karex so strong ha? From $0.565shoot up to$0.650 within 2 weeks time?
Any news?
2023-11-20 18:10
@xiaoeh, all glove counters are turning around. From negative earnings to positive earnings. Karex is following the gloves stocks. The 1st quarter results will be released next Monday. Expected target price is RM0.72.
2023-11-20 18:47
Still manage to turn from -0.005 to +0.010 and closed at RM0.705. The AGM and 1st quarter results are on next Monday (27 Nov 2023). The target price still maintains at RM0.72.
2023-11-21 17:04
By the end of the first half of the financial year 2024 (28 Feb 2024), the FDA (Food and Drug Administration) of US should have approved the new 001 condoms to be exported to US. The price of Karex will move north.
2023-11-21 17:08
Sold all at RM0.690 and RM0.685. Got to follow the bears. I shifted to poultry counter LHI (Lay Hong International).
2023-11-22 19:13
001 condoms are by karex? I thought there are by Okamoto. One condom released a Graphene condom 1 month ago is US
2023-11-24 15:38
Very good 1st quarter results. Next Monday should rebound with high volume.
2023-11-24 18:59
Posted by xiaoeh > 4 days ago | Report Abuse
Good exit point in technical term Chloe.
Walao...
my technical got a lot of rooms to improve
2023-11-27 21:36
in my watchlist
still expensive to accumulate
waiting @ 0.60-0.65 :)
2024-01-19 12:31
I went in today (2 Feb 2024). There is nothing much that I could do now. Just wait until end of February to see whether its quarter results is good enough or not. Bears are in full control now.
2 months ago
The long tail below the body is indicative of sellers trying to push the price down by a significant amount but the buyers manage to push it back up. The buyers do this to show a definitive buying strength which will lead to an increase in price, going forward.
2 months ago
wasted
look for cheap now even more expensive
good stuff won't get cheap
it happened many times 😂
2 months ago
KAREX is riding on the strong growth in the condom industry, focusing on high-margin products which will take its profitability to a higher level. It is penetrating high-growth markets with premium offerings backed by innovation and strict compliance with international standards. We project its earnings to double in FY24, followed by another 88% surge in FY25. We initial coverage on KAREX with an OUTPERFORM rating and a TP of RM1.00.
Kenanga Research
2 months ago
Read and listen to the words from Karex CEO. "Karex pivots beyond latex condoms". Results have been better quarter over quarter for 5 consecutive quarters. He said 26 Feb 2024 will also be better than the previous quarter. New products are lubricant and gloves.
2 months ago
Please understand that RM0.87 at this moment is not Karex all time high. Its all time high was RM3.10 on 11.3.2016. It is unlike Sunway, MBMR, HUMEIND, etc.
2 months ago
Still thinking very hard whether or not I should bet on Karex next Monday, with its 2nd quarter results after 5 pm. Now 0.835 and the highest 0.87.
2 months ago
Very, very good 2nd quarter results:
PAT 2nd quarter FY 2024: RM7,324 mil [compared to PAT 2nd quarter FY2023: RM2,025 million, which is an increased of 262% YoY]
PAT 2nd quarter FY 2024: RM7,324 mil [compared to PAT 1st quarter FY2024: RM5,256 million, which is an increased of 39% QoQ]
Hopefully, the operator will help to break the 52-week ATH of RM0.87, starting 27 Feb 2024
2 months ago
The heyday of being the sole and top condom manufacturer in Malaysia is over for Karex Bhd. I used to own a significant number of Karex shares, but it saddens me that the management has failed to turn the company around even after many years. I don't believe Karex will recover to its previous highs
1 month ago
Agree with Kenanga's analyst with regards to the emphasis on improving margins by the company. However, the focus on premium products is not really feasible cause condom users do not place much importance on the actual quality of the products compared to other consumer staples.
There is no way for the company to bring the sales volume/total sales back to 2016 levels because the competition within the condom market is surging. Despite the recent introduction of abortion laws in the US, there isn't any significant uptick in sales for the US market which is a bit disappointing.
However, there still remains a few tailwinds for the condom market and near-term catalysts for Karex. Such as weaker Ringgit, and the stabilisation of raw material/labour cost. And the diversification/venture into gloves and lubricant products, on top of the company's healthy balance sheet.
My mid-term PT is about RM0.90
1 month ago
Consolidation shall finished..
$1.06 kenanga target coming..
KAREX is the largest condom Mfg in the world..
It need to reflect its strength but not below $1 penny world class
1 month ago
Post a Comment
Featured Posts
New Update. Discover investment communities that resonate with your ideas
One App To Trade Malaysia & US Stock With 0* Commission
MQ Trading Signals
Time
Signal
Duration
Type
2024-04-26 16:30:00
EMA 5
30 Mins
BUY
2024-04-26 16:15:00
EMA 5
5 Mins
BUY
2024-04-26 16:10:00
EMA 5
5 Mins
SELL
2024-04-26 16:00:00
EMA 5
Hourly
BUY
2024-04-26 16:00:00
EMA 5
30 Mins
BUY
Apps
Top Articles
1
RHB Investment Research Reports
3
save malaysia!
4
5
6
7
8
CEO Morning Brief
YTL Corp Rallies to New All-time High After HLIB Flags More Upside
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Vhydro
ChloeTai, you got support Karex by buying condom to use onot?
2023-11-15 21:56